Lupus-erythematosus-like eruption induced by Trichophyton mentagrophytes infection.
BACKGROUND
Several factors are known to trigger acute manifestations of lupus erythematosus (drugs, ultraviolet radiation, bacterial or viral infections, pregnancy), but fungal infections have never been reported to induce lupus-like lesions. We describe 2 children with tinea capitis caused by Trichophyton mentagrophytes(TM), who developed transient skin and serological manifestations of systemic lupus erythematosus.


METHODS
Case 1, a 3-year-old girl, had a kerion due to TM transmitted by an octodon, and a facial skin eruption suggestive of systemic lupus erythematosus. Antinuclear antibodies (ANA) were positive at 1:250. After griseofulvin treatment, the lupus-like rash completely regressed, and the ANA titre decreased. Case 2, a 4-year-old girl, had occipital kerion and an annular scaly erythema on the shoulder caused by TM. She also had a non-scaly rash on the face and a recent history of photosensitivity. The ANA titre was positive at 1:8,000. Cutaneous lesions disappeared after an 8-week griseofulvin therapy, and ANA titres decreased progressively.


CONCLUSIONS
'New pets' are usually the vectors of TM, especially familiar rodents like the degu of Chile (also named octodon). In our 2 cases, lupus-like rashes began before the onset of griseofulvin treatment, suggesting a pathogenic role of the dermatophyte. A wide variety of lesions named 'mycides' was described several decades ago associated with TM infections. We hypothesize that these mycides and the TM-induced lupus-like lesions reported in our 2 cases could represent the same entity.
Boralevi
F
F
Unité de dermatologie pédiatrique, Hôpital Pellegrin-Enfants, Bordeaux, France.
Léauté-Labrèze
C
C
Roul
S
S
Couprie
B
B
Taïeb
A
A
D000818:Animals; D000829:Animals, Domestic / Q000382:microbiology; D000935:Antifungal Agents / Q000627:therapeutic use; D002675:Child, Preschool; D005260:Female; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000382:microbiology*; D012377:Rodentia / Q000382:microbiology*; D014006:Tinea Capitis / Q000150:complications* / Q000188:drug therapy; D016896:Treatment Outcome; D014249:Trichophyton / Q000302:isolation & purification*
D000935:Antifungal Agents; D006118:Griseofulvin